Skip to main content
Top
Published in: Indian Journal of Otolaryngology and Head & Neck Surgery 2/2024

07-01-2024 | Amphotericin B | Original Article

Minimizing the Recurrence Rate in Covid Associated Mucormycosis: Our Experience in 500 Patients

Authors: Anchal Kumar Jain, Yamini Gupta, Jagram Verma, Surbhi Godha, Indra Prakash Prajapati

Published in: Indian Journal of Otolaryngology and Head & Neck Surgery | Issue 2/2024

Login to get access

Abstract

Mucormycosis is an aggressive, fatal fungal infection. The fungal organisms are ubiquitous and easily affect immunocompromised patients. The main aim of this article is to emphasize over the knowledge of different diagnostic methods (diagnostic nasal endoscopy, ct/ contrast mri pns + orbit + brain, Wet KOH mount), the importance of practising an aggressive surgical resection, medical treatments (liposomal amphotericin B, amphotericin gel, tablet posaconazole, nasal douching, retrorbital amphotericin injection), suction cleaning and regular follow up of the patient after surgical management. This can greatly help in minimizing the recurrence of mucormycosis even in immunocompromised patients in a population. The study performed was a prospective study conducted from April 2021 to July 2021 in which we included 500 patients who presented to the OPD & Department of ENT or Emergency Department of Maharaja Yashwantrao Hospital with complaints suggestive of mucormycosis. The patients who were surgically fit were operated. Out of the 500 patients who were diagnosed with Mucormycosis, from April 2021 to July 2021 complete cure was achieved in 456 patients( 91.2%) and only 44 patients (8.8%) have shown recurrence due to various causes (specially those who did not came for regular follow up). Rhinorbital was the most common site to be involved. In the study it was found that most of the patients which showed recurrence were male, post covid and immunocompromised. Diabetes mellitus was found to be most common among immunocompromised patients. The recurrence in patients with mucormycosis can be minimise by educating the masses regarding importance of public and personal hygiene, and multidisciplinary management with regular follow up offers a better approach to treat this life-threatening condition. The study shows the importance of clinical diagnosis, concurrent surgical treatment, medical treatment, post op care, suction cleaning and regular follow up advice. It is necessary us to take the step forward in this regard, so that in the future we will be better prepared for such type of epidemic.
Literature
1.
go back to reference Panneerselvam K, Kumar MS, Karthikeyan, Mohan AM (2020) Recurrent mucormycosis—better understanding of treatment and management. J Fam Med Prim Care 9(12):6279–6281CrossRef Panneerselvam K, Kumar MS, Karthikeyan, Mohan AM (2020) Recurrent mucormycosis—better understanding of treatment and management. J Fam Med Prim Care 9(12):6279–6281CrossRef
2.
go back to reference Rai S, Misra D, Misra A, Jain A, Jain P, Dhawan A (2018) Palatal mucormycosis masquerading as bacterial and fungal osteomyelitis: a rare case report. Contemp Clin Dent 9(2):309–313CrossRefPubMedPubMedCentral Rai S, Misra D, Misra A, Jain A, Jain P, Dhawan A (2018) Palatal mucormycosis masquerading as bacterial and fungal osteomyelitis: a rare case report. Contemp Clin Dent 9(2):309–313CrossRefPubMedPubMedCentral
4.
go back to reference Lim S, Bae JH, Kwon H-S, Nauck MA (2021) COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat Rev Endocrinol 17(1):11–30CrossRefPubMed Lim S, Bae JH, Kwon H-S, Nauck MA (2021) COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat Rev Endocrinol 17(1):11–30CrossRefPubMed
7.
go back to reference Spellberg B, Edwards J, Ibrahim A (2005) Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev 18(3):556–569CrossRefPubMedPubMedCentral Spellberg B, Edwards J, Ibrahim A (2005) Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev 18(3):556–569CrossRefPubMedPubMedCentral
8.
go back to reference Rammaert B, Lanternier F, Poirée S, Kania R, Lortholary O (2012) Diabetes and mucormycosis: a complex interplay. Diabetes Metab 38(3):193–204CrossRefPubMed Rammaert B, Lanternier F, Poirée S, Kania R, Lortholary O (2012) Diabetes and mucormycosis: a complex interplay. Diabetes Metab 38(3):193–204CrossRefPubMed
10.
go back to reference Price JC, Stevens DL (1980) Hyperbaric oxygen in the treatment of rhinocerebral mucormycosis. Laryngoscope 90(5 Pt 1):737–747CrossRefPubMed Price JC, Stevens DL (1980) Hyperbaric oxygen in the treatment of rhinocerebral mucormycosis. Laryngoscope 90(5 Pt 1):737–747CrossRefPubMed
11.
go back to reference Reed C, Bryant R, Ibrahim AS, Edwards J, Filler SG, Goldberg R et al (2008) Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis. Clin Infect Dis 47(3):364–371CrossRefPubMed Reed C, Bryant R, Ibrahim AS, Edwards J, Filler SG, Goldberg R et al (2008) Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis. Clin Infect Dis 47(3):364–371CrossRefPubMed
Metadata
Title
Minimizing the Recurrence Rate in Covid Associated Mucormycosis: Our Experience in 500 Patients
Authors
Anchal Kumar Jain
Yamini Gupta
Jagram Verma
Surbhi Godha
Indra Prakash Prajapati
Publication date
07-01-2024
Publisher
Springer India
Published in
Indian Journal of Otolaryngology and Head & Neck Surgery / Issue 2/2024
Print ISSN: 2231-3796
Electronic ISSN: 0973-7707
DOI
https://doi.org/10.1007/s12070-023-04442-5

Other articles of this Issue 2/2024

Indian Journal of Otolaryngology and Head & Neck Surgery 2/2024 Go to the issue